We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Photograph of the Agilent Measurement Suite at Imperial College London taken through the window.
Industry Insight

Flagship Facility Supports Advanced Analytical Science

We spoke to Prof. Oscar Ces, head of the Department of Chemistry at Imperial College London (ICL), to find out about the evolution of ICL’s White City Campus, the Agilent Measurement Suite and what it means for scientists across the board.
Protein structure.
Industry Insight

Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research

Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Cancer patient with a line in her arm talking to a medic with a stethoscope around her neck.
Industry Insight

Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies

Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
A picture depicting proteins within a cell.
Industry Insight

Increasing Throughput While Protecting Proteome Coverage

At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Hexagons containing symbols related to health.
Industry Insight

Advancing Biomedicine With Single-Molecule Proteomics

Unlocking more information from our proteome could deepen our understanding of disease, improve detection and influence drug selection. To find out more about single-molecule proteomics, we spoke to Parag Mallick, co-founder of Nautilus Biotech.
An image depicting single-cell sequencing.
Industry Insight

Advances in Mass Spectrometry Drive Immunopeptidomics

At the 71st Annual Society for Mass Spectrometry (ASMS) meeting, Technology Networks had the pleasure of speaking with Rohan Thakur, president of Life Sciences Mass Spectrometry at Bruker Daltonics. We discussed the new product launches from Bruker and focused specifically on the applications of the company’s newest mass spectrometer, the timsTOF Ultra, for immunopeptidomics.
10th birthday candle and confetti.
Industry Insight

A Decade of DIA and Key Milestones: The 10-Year Anniversary of SWATH DIA

The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.
Connecting hexagons each with a symbol relating to health, medicine and data.
Industry Insight

The Impact of Proteomics on Precision Oncology

To find out more about how proteomics is providing new insights into cancer dynamics and resistance mechanisms, we spoke to Dr. Ofer Sharon, CEO of OncoHost, a precision diagnostics company.
Computer-generated image of a DNA double helix.
Industry Insight

Advances in DNA Methylation Profiling and Biomarker Discovery

Technology Networks spoke with Anjali Pradhan, senior vice president of product management at Mission Bio, to discuss a new application for DNA methylation analysis, and its potential in uncovering new biological insights and biomarkers that may guide the future of cancer research.
What Do Advances in Structural Proteomics Mean for Drug Development? content piece image
Industry Insight

What Do Advances in Structural Proteomics Mean for Drug Development?

This article will cover innovations in structural proteomics, a new way to identify drug targets across the proteome, a new method to dissect drug–protein interactions and the future of structure-based drug design.
Advertisement